Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau on September 21, 2006 and is headquartered in Hellerup, Denmark.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Ascendis Pharma A/S?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Ascendis Pharma A/S market cap is $13.6B.
What is the 52-week high for Ascendis Pharma A/S?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Ascendis Pharma A/S 52 week high is $250.74 as of June 16, 2026.
What is the 52-week low for Ascendis Pharma A/S?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Ascendis Pharma A/S 52 week low is $160.86 as of June 16, 2026.
What is Ascendis Pharma A/S stock price today?
Ascendis Pharma A/S stock price today is $223.29.
What was Ascendis Pharma A/S stock price yesterday?
Ascendis Pharma A/S stock price yesterday was $218.06.
What is the PE ratio of Ascendis Pharma A/S?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Ascendis Pharma A/S's P/E ratio is 23.76.
What is the Price-to-Book ratio of Ascendis Pharma A/S?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Ascendis Pharma A/S P/B ratio is 24.6671.
What is the 50-day moving average of Ascendis Pharma A/S?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Ascendis Pharma A/S 50-day moving average is $231.50.
